Revolver Therapeutics

Pre-Seed
revolvertherapeutics.com Biotech & Healthcare Bath, United Kingdom
Total Funding $763K
Latest Round $763K Pre-Seed
Last Announced Jul 3, 2026
Investors Undisclosed
Decision Makers 1 Verified

About Revolver Therapeutics

Revolver Therapeutics develops peptide therapeutics using a screening platform to target transcription factors for cancer treatment.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Pre-Seed
Global Headquarters Bath, United Kingdom
Tracked Since Oct 2, 2026

Web & Domain Identity

Domain Registered Date Jun 2, 2025

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $763,334 · Pre-Seed

    University of Bath

  2. Milestone

    Website domain registered

    revolvertherapeutics.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Revolver Therapeutics.

Funding History

1 Round
Pre-Seed · Jul 3, 2026

Founders & Leadership

1

Jody Mason

Founder & CSO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts